Accelerating More Sensitive, Quantitative and Predictive Serological and Imaging Biomarkers to Transform Clinical Development in the CNS. With the Donanemab ADCOM hailing fluid...

Welcome to the 9th CDD for Biologics Summit For the past eight years, the CDD for Biologics Summit has united computational and structural biologists, along with protein and...

Join us for SAE Media Group's 2nd Annual RNA Therapeutics USA Conference on October 23-24, 2024, at Courtyard by Marriott Boston Downtown. RNA therapies are at the forefront of...

Those of you who provide care for people with (or at risk of) diabetes know that these patients often have a myriad of comorbidities and complications, and that optimizing...

The 18th Annual Pain Therapeutics Summit serves as a catalyst for collaboration between academia, industry, and regulatory bodies, fostering a multidisciplinary exchange of...

With a flurry of high capital collaborations and partnership deals from the likes of C4T, Merck US and KgGA, Monte Rosa, Proxygen, Orum, and momentum building in clinic with...

The surge of ground-breaking updates in Geographic Atrophy, along with significant advancements in developing robust biomarkers and functional endpoints, has ignited a wave of...

Digitalization and centralization of datasets have vastly increased the volume of RWD. Advances in AI, deep learning, and large language models have revolutionized big data...

Staying current with the rapid advances in laser and aesthetic skin therapy is an increasingly important challenge for physicians. Our patients' demand for such services has...

Turbocharged by increased LNP pipeline development and technological advancements with SPARTA biodiscovery raising $4.3m for their characterization technology, UPENN engineers...

What is this meeting about? Diabetic foot problems significantly impair the quality of life of diabetic patients. Each year in the United States, these complications lead to...

As we reach a critical tipping point in climate action, it is no longer an option to ignore the impact of agricultural supply chains. The Carbon Accounting in Agricultural...

Join us for the RE•WORK AI in Healthcare and Pharma Summit happening on November 13-14, 2024, at the Boston Marriott Copley Place Hotel. Discover advances in AI tools and...

Supercharge Your R and D, Diagnostic and GMP Operations Across Asset and Facilities' Productivity, Capital Efficiency and Sustainability through Integration and Automation...

As drug developers continue to utilize the expedited FDA regulatory pathway available for CBD, alongside a growing interest in the therapeutic benefits and regulatory approval...

Designed for the CHRO/CPO/Head of HR at the Heart of Emerging Biopharma Organizations Mark your calendars for November because LEAP HR: Emerging Biopharma is back! Returning to...

As generative AI fuels the rise of AI-driven software in medical devices, the growing connectivity of legacy systems leaves them increasingly exposed to cyberattacks. With the...

The inaugural Portfolio Strategy and Decision Making for Biopharma Summit is a must-attend event for leaders in the pharma and biotech industries who are aiming to refine their...

Liquid biopsies are revolutionizing clinical trials, emerging as a game-changing diagnostic tool for monitoring molecular residual disease and detecting disease resistance....

With recent advancements into Phase II and III trials for personalized cancer vaccines along with 437 other candidates in development, the biopharma industry is at a critical...

Welcome to the Cell and Gene Therapy Medical Affairs Summit! Delivering Impactful Education to Transform Patient Outcomes Introducing the Cell and Gene Therapy Medical Affairs...

CNS drug development is facing a new era, thanks to huge strides in neuroscience innovation, including advances in blood-brain barrier transport, CSF administration, and...

The landscape of internal medicine is evolving rapidly, presenting practicing clinicians with increasingly complex challenges to maintain cutting-edge patient care. In response...

With the applications of LNPs rapidly expanding beyond vaccines, as well as beyond the liver, it is of utmost importance to predict and minimize adverse reactions to guarantee...

In the face of unprecedented cost-per-patient expenses, the FDA's recent focus on rare disease, and a myriad of options for identifying, engaging, screening, and retaining...

With recent accelerated approval wins, positive clinical trial readouts, progression through clinical pipelines and exciting mergers and acquisitions, it has certainly been an...

Uniting Large Pharma, Innovative Biotech and Leading Academics to Eliminate the Boundaries of Druggability with Novel Covalent Drugs With continued advancements in screening...

With Remix Therapeutics joining forces with Roche and Daiichi Sankyo partnering with Depixus, there has been many valuable collaborations entering the RNA-targeting field...

Achieving Efficacy and Exploring Indication Expansion for Complement Inhibitors The complement community is shifting gear, with more companies than ever targeting alternative...

Making Strides in Targeting PARP, ATR, ATM, WEE1 and POLθ AstraZeneca and Merck are at the forefront of DDR inhibitor development, focusing on next-generation PARP inhibitors...